These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8638637)

  • 1. Idiopathic myelofibrosis with unusually high erythroblastosis in the peripheral blood.
    Osman Y; Kishi K; Narita M; Saito H; Masuko M; Koike T; Shibata A
    Am J Hematol; 1996 Jun; 52(2):122-3. PubMed ID: 8638637
    [No Abstract]   [Full Text] [Related]  

  • 2. Idiopathic myelofibrosis with prominent postsplenectomy erythroblastosis terminating in acute myeloid transformation.
    Tóth P; Tóth Z
    Haematologia (Budap); 2002; 32(2):155-61. PubMed ID: 12412736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. When nucleated RBCs "count" in the peripheral blood: a unique case of post-essential thrombocythemia myelofibrosis.
    Thompson M; Lynch D
    Blood; 2019 Apr; 133(15):1696. PubMed ID: 30975644
    [No Abstract]   [Full Text] [Related]  

  • 4. [Erythrocyte pool of the spleen in myeloproliferative and lymphoproliferative diseases].
    Friedmann B; Voslárová Z; Hermanský F; Lodrová V
    Vnitr Lek; 1974 Jul; 20(6):539-46. PubMed ID: 4844788
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pathogenesis of Vaughan's erythromyelosis].
    Abramov MG
    Ter Arkh; 1987; 59(6):125-6. PubMed ID: 3629489
    [No Abstract]   [Full Text] [Related]  

  • 6. [Study of erythrocyte survival in relation to the predominant sites of their destruction in patients with osteomyelosclerosis and myelofibrosis].
    Sakhibov IaD; Aripov AIa
    Ter Arkh; 1968 Apr; 40(4):92-7. PubMed ID: 5740515
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of chemotherapy on tear drop poikilocytes and other peripheral blood findings in myelofibrosis.
    Manoharan A; Hargrave M; Gordon S
    Pathology; 1988 Jan; 20(1):7-9. PubMed ID: 3374975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Marked increase in eosinophils and atypical lymphocytes in a case of idiopathic myelofibrosis diagnosed at autopsy].
    Saito H; Nishi M; Moriyama Y; Hirasawa K; Onishi Y
    Rinsho Ketsueki; 1974 Jul; 15(7):731-8. PubMed ID: 4473582
    [No Abstract]   [Full Text] [Related]  

  • 9. Idiopathic myelofibrosis.
    Barosi G; Hoffman R
    Semin Hematol; 2005 Oct; 42(4):248-58. PubMed ID: 16210038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Idiopathic myelofibrosis: clinical, physiopathological and therapeutic aspects].
    Storti E; Perugini S
    Omnia Med Ther; 1968; 46(3):501-63. PubMed ID: 5748312
    [No Abstract]   [Full Text] [Related]  

  • 11. Idiopathic myelosclerosis (report of a case).
    Ambrose LD; Vijayan AK; Priyadarsini AG; Venugopal P
    J Assoc Physicians India; 1980 Jul; 28(7):201-5. PubMed ID: 7204319
    [No Abstract]   [Full Text] [Related]  

  • 12. Peripheral monocytes and CD4+ cells are potential sources for increased circulating levels of TGF-beta and substance P in autoimmune myelofibrosis.
    Harrison JS; Corcoran KE; Joshi D; Sophacleus C; Rameshwar P
    Am J Hematol; 2006 Jan; 81(1):51-8. PubMed ID: 16369977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Myelofibrosis with myeloid metaplasia. A study of 24 consecutive patients].
    Bettini R; Redaelli S; Marzetta K; Maino C; Sala D; Saccà V; Gorini M
    Recenti Prog Med; 2004; 95(7-8):358-64. PubMed ID: 15303545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiopathic myelofibrosis with neutrophil myeloperoxidase deficiency: a case report.
    Caenazzo A; Piva E; Sartori D; Stefani PM
    Haematologica; 1997; 82(4):465-7. PubMed ID: 9299865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic idiopathic myelofibrosis: prognostic impact of myelofibrosis and clinical parameters on event-free survival in 122 patients who presented in prefibrotic and fibrotic stages. A retrospective study identifying subgroups of different prognoses by using the RECPAM method.
    Kreft A; Weiss M; Wiese B; Choritz H; Buhr T; Büsche G; Georgii A
    Ann Hematol; 2003 Oct; 82(10):605-11. PubMed ID: 14564478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cases of myelofibrosis with an unusual course].
    Klimova NF; Zakharova AV
    Probl Gematol Pereliv Krovi; 1977 Jan; 22(1):52-4. PubMed ID: 834742
    [No Abstract]   [Full Text] [Related]  

  • 17. A case of Philadelphia-chromosome positive chronic idiopathic myelofibrosis.
    Chen F; Zhang C; Wang W; Li L; Yan S; Sun J; Zhang M; Ji C; Hou M
    Leuk Res; 2008 Apr; 32(4):665-7. PubMed ID: 17854891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with valproic acid for myelofibrosis with myeloid metaplasia.
    Inoue Y; Suzuki T; Takimoto M; Irei M; Yoshioka S; Shibuya Y; Kato M; Koike M; Takahashi M
    Ann Hematol; 2005 Nov; 84(12):833-4. PubMed ID: 16132902
    [No Abstract]   [Full Text] [Related]  

  • 19. [Blood protein spectrum in subleukemic myelosis].
    Guseva SA
    Vrach Delo; 1984 Mar; (3):56-9. PubMed ID: 6719902
    [No Abstract]   [Full Text] [Related]  

  • 20. [Peripheral blood cell culture in myelosclerosis (author's transl)].
    Schmitt M; Mayer S
    Nouv Rev Fr Hematol Blood Cells; 1977; 18(3):573-81. PubMed ID: 600777
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.